ClinConnect ClinConnect Logo
Search / Trial NCT02990572

Amish/Mennonite Research Contact Registry

Launched by UNIVERSITY OF PITTSBURGH · Dec 8, 2016

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Amish Mennonite

ClinConnect Summary

The Amish/Mennonite Research Contact Registry is a project aimed at finding members of the Amish and Mennonite communities who are interested in taking part in future medical research studies. The goal is to learn more about health issues that specifically affect these communities, using their family medical histories to identify individuals who may be suitable for participation in upcoming studies.

To be eligible, participants need to be Amish or Mennonite and at least 18 years old, or children with a parent's permission. The registry is currently looking for both men and women from these communities, regardless of their health conditions. Participants can expect to be contacted when research opportunities arise that match their backgrounds, helping to advance our understanding of health issues in these groups. It's important to note that individuals who do not speak English or are not part of the Amish or Mennonite communities cannot join the registry.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Amish and Mennonite men and women age 18 or older
  • Amish and Mennonite children with the permission of a parent
  • Exclusion Criteria:
  • Amish and Mennonite men and woman age 18 or older who do not speak English
  • Those who are not Amish or Mennonite

About University Of Pittsburgh

The University of Pittsburgh is a leading research institution known for its commitment to advancing medical science and improving patient care through innovative clinical trials. With a robust infrastructure for research and a multidisciplinary approach, the university fosters collaboration among experts in various fields, facilitating the development of novel therapies and interventions. Its clinical trial programs emphasize ethical standards, patient safety, and the integration of cutting-edge technology, making the University of Pittsburgh a pivotal contributor to the landscape of clinical research and a trusted partner in the pursuit of health advancements.

Locations

Pittsburgh, Pennsylvania, United States

Patients applied

0 patients applied

Trial Officials

Lina Ghaloul Gonzalez, MD, PhD

Principal Investigator

University of Pittsburgh

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials